Appropriate prescribing in asthma

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6986.1069b (Published 22 April 1995) Cite this as: BMJ 1995;310:1069

PACT data have drawbacks

  1. Mark Campbell,
  2. D Nicholas Bateman,
  3. Sarah J Roberts,
  4. James M Smith
  1. Manager, prescribing unit Medical director Lectuer in medical statistics Regional pharmaceutical adviser NHS Executive, Northern and Yorkshire Regional Health Authority, Regional Drug and Therapeutics Centre, Wolfson Unit, Newcastle upon Tyne NE1 4LP

    EDITOR,—Jeannette Naish and colleagues describe the variations in the costs of prescribing respiratory drugs among general practices in one family health services authority.1 While it is possible that better asthma care results in higher prescribing costs, the use of costs from prescribing analysis and cost (PACT) data to derive the volume of prescribing for asthma has two major drawbacks.

    Firstly, PACT data are not linked to indication, and therefore one cannot assume …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription